Johnson & Johnson has rewarded shareholders with a quarterly dividend. As a Dividend King, it is the epitome of a steady and ...
Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...
This virtually unknown company has been paying a continuous dividend for six decades longer than any other U.S. stock.
JNJ's $14B acquisition of ITCI bolsters its portfolio with Caplyta, showing strong sales and patent protection until 2033.
U.S. stocks were resuming their slide Thursday morning, fueled by concern over AI revenue and Trump’s tariffs.
Wall Street lost momentum before the opening bell Tuesday and markets in Europe and Asia slid. The declines added to a big selloff Monday. Futures for the S&P 500 and Nasdaq each fell 0.6% in ...